Spain downplays TB plan but Dx interface is clear
This article was originally published in Clinica
Executive Summary
The Spanish government is playing down the significance to human healthcare of an animal TB mapping project, but the national veterinary surveillance unit behind the diagnostics development initiative already interfaces with the health ministry. Also, the animal TB strains that will be most closely monitored in the agriculture ministry's project have emerged in several human cases of infection in recent years, according to data provided to Clinica.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.